International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

December 31, 2026

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2032

Conditions
Coronary Artery DiseaseCognitive ImpairmentHeart Failure
Interventions
PROCEDURE

Guideline-directed medical therapy (GDMT)

Participants receive guideline-directed medical therapy (GDMT).

PROCEDURE

Coronary artery bypass grafting (CABG)

Participants receive coronary artery bypass grafting (CABG).

PROCEDURE

Percutaneous coronary intervention (PCI).

Participants receive percutaneous coronary intervention (PCI).

Trial Locations (6)

10016

NYU Langone Health, New York

Unknown

International Study Site, International Study Site

International Study Site, International Study Site

International Study Site, International Study Site

International Study Site, International Study Site

International Study Site, International Study Site

All Listed Sponsors
lead

NYU Langone Health

OTHER